Landscapes / Targets
Factor XIa
1 drug acts on Factor XIa, in 2 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs1
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Factor XIa inhibitor |
Johnson & Johnson (Janssen) +1 · Public JNJ · BMY |
Phase 3 | 8 Dec 2026soonPhase 3 trial completes | ||
| Next date | 8 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Ischemic Stroke; Ischemic Attack, Transient, Atrial Fibrillation | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 1 of 1 drug. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026